Study of MORF 057 to Evaluate Single and Multi Ascending Doses in Healthy Volunteers
NCT04580745
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
67
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
MORF-057
DRUG:
Placebo for MORF-057
Sponsor
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)